{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:42:18Z","timestamp":1791524538482,"version":"4.3.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["945345-2"],"award-info":[{"award-number":["945345-2"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015756","name":"Cilag","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015756","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014915","name":"Juvenile Diabetes Research Foundation Netherlands","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.lungcan.2022.08.021","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T19:02:56Z","timestamp":1662404576000},"page":"5-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Development of an updated, standardized, patient-centered outcome set for lung cancer"],"prefix":"10.1016","volume":"173","author":[{"given":"Belle H.","family":"de Rooij","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina","family":"van den Hurk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerle","family":"Smaardijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paz","family":"Fernandez-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Navarro-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Barberio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Guckenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severin","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Walraven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Vallow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Kotsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Preusser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Mosor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jente M.","family":"Klok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Milani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyudmil","family":"Ninov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lonneke V.","family":"van de Poll-Franse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2022.08.021_b0005","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.33588","article-title":"Cancer statistics for the year 2020: An overview","author":"Ferlay","year":"2021","journal-title":"International Journal of Cancer"},{"issue":"10125","key":"10.1016\/j.lungcan.2022.08.021_b0010","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000\u201314 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"Allemani","year":"2018","journal-title":"The Lancet."},{"key":"10.1016\/j.lungcan.2022.08.021_b0015","article-title":"Small cell lung cancer","author":"Basumallik","year":"2020","journal-title":"StatPearls [internet]."},{"key":"10.1016\/j.lungcan.2022.08.021_b0020","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2147\/CMAR.S187317","article-title":"Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades","volume":"11","author":"Lu","year":"2019","journal-title":"Cancer management and research."},{"issue":"7","key":"10.1016\/j.lungcan.2022.08.021_b0025","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1916623","article-title":"The effect of advances in lung-cancer treatment on population mortality","volume":"383","author":"Howlader","year":"2020","journal-title":"New England Journal of Medicine."},{"issue":"101","key":"10.1016\/j.lungcan.2022.08.021_b0030","doi-asserted-by":"crossref","first-page":"37589","DOI":"10.18632\/oncotarget.26428","article-title":"Targeted therapies for advanced non-small cell lung cancer","volume":"9","author":"Ai","year":"2018","journal-title":"Oncotarget."},{"issue":"7","key":"10.1016\/j.lungcan.2022.08.021_b0035","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jtho.2021.03.016","article-title":"Efficacy and safety of first-line immunotherapy combinations for advanced NSCLC: a systematic review and network meta-analysis","volume":"16","author":"Liu","year":"2021","journal-title":"Journal of Thoracic Oncology."},{"issue":"8","key":"10.1016\/j.lungcan.2022.08.021_b0040","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s12094-018-02011-9","article-title":"The role of immunotherapy in small cell lung cancer","volume":"21","author":"Calles","year":"2019","journal-title":"Clinical and Translational Oncology."},{"key":"10.1016\/j.lungcan.2022.08.021_b0045","article-title":"Value-based healthcare delivery models in oncology: A systematic review. American Society of","author":"Aviki","year":"2018","journal-title":"Clinical Oncology"},{"issue":"3","key":"10.1016\/j.lungcan.2022.08.021_b0050","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1183\/13993003.02049-2015","article-title":"Defining a standard set of patient-centred outcomes for lung cancer","volume":"48","author":"Mak","year":"2016","journal-title":"European Respiratory Journal."},{"issue":"5","key":"10.1016\/j.lungcan.2022.08.021_b0055","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jtho.2016.03.012","article-title":"Scientific advances in lung cancer 2015","volume":"11","author":"Tsao","year":"2016","journal-title":"Journal of Thoracic Oncology."},{"key":"10.1016\/j.lungcan.2022.08.021_b0060","article-title":"Patient reported toxicities: Development and validation of patient-reported symptom measure for lung cancer patients receiving immunotherapy. American Society of","author":"Shaw","year":"2019","journal-title":"Clinical Oncology"},{"issue":"7","key":"10.1016\/j.lungcan.2022.08.021_b0065","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1002\/cncr.32692","article-title":"Development of the Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator (FACT-ICM): A toxicity subscale to measure quality of life in patients with cancer who are treated with ICMs","volume":"126","author":"Hansen","year":"2020","journal-title":"Cancer."},{"issue":"3","key":"10.1016\/j.lungcan.2022.08.021_b0070","article-title":"Building a Value-Based Care Infrastructure in Europe: The Health Outcomes Observatory","volume":"2","author":"Stamm","year":"2021","journal-title":"NEJM Catalyst Innovations in Care Delivery."},{"key":"10.1016\/j.lungcan.2022.08.021_b0075","doi-asserted-by":"crossref","unstructured":"Williamson PR, Altman DG, Bagley H, Barnes KL, Blazeby JM, Brookes ST, et al. The COMET Handbook: version 1.0. Trials. 2017;18(Suppl 3):280.","DOI":"10.1186\/s13063-017-1978-4"},{"issue":"1","key":"10.1016\/j.lungcan.2022.08.021_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-015-0465-6","article-title":"A scoping review of rapid review methods","volume":"13","author":"Tricco","year":"2015","journal-title":"BMC medicine."},{"issue":"4","key":"10.1016\/j.lungcan.2022.08.021_b0085","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology."},{"key":"10.1016\/j.lungcan.2022.08.021_b0090","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2288-5-37","article-title":"Stability of response characteristics of a Delphi panel: application of bootstrap data expansion","volume":"5","author":"Akins","year":"2005","journal-title":"BMC Med Res Methodol."},{"key":"10.1016\/j.lungcan.2022.08.021_b0095","unstructured":"COMET. DelphiManager. COMET; 2016."},{"key":"10.1016\/j.lungcan.2022.08.021_b0100","article-title":"A Language and Environment for Statistical","year":"2013","journal-title":"Computing"},{"key":"10.1016\/j.lungcan.2022.08.021_b0105","doi-asserted-by":"crossref","unstructured":"Escudero-Vilaplana V, Calles A, Collado-Borrell R, Bel\u00e9n Marzal-Alfaro M, Polanco C, Garrido C, et al. Standardizing Health Outcomes for Lung Cancer. Adaptation of the International Consortium for Health Outcomes Measurement Set to the Spanish Setting. Frontiers in oncology. 2020:1645. https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2020.01645\/full.","DOI":"10.3389\/fonc.2020.01645"},{"issue":"1","key":"10.1016\/j.lungcan.2022.08.021_b0110","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jval.2012.10.017","article-title":"Core domains for a person-focused outcome measurement system in cancer (PROMS-Cancer Core) for routine care: a scoping review and Canadian Delphi Consensus","volume":"16","author":"Howell","year":"2013","journal-title":"Value in health."},{"issue":"2","key":"10.1016\/j.lungcan.2022.08.021_b0115","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11764-020-00924-5","article-title":"A core set of patient-reported outcomes for population-based cancer survivorship research: A consensus study","volume":"15","author":"Ramsey","year":"2021","journal-title":"Journal of Cancer Survivorship."},{"key":"10.1016\/j.lungcan.2022.08.021_b0120","unstructured":"Milani A, Mauri S, Gandini S, Magon G. Oncology Nursing Minimum Data Set (ONMDS): can we hypothesize a set of prevalent Nursing Sensitive Outcomes (NSO) in cancer patients? ecancermedicalscience. 2013;7. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3757958\/."},{"issue":"4","key":"10.1016\/j.lungcan.2022.08.021_b0125","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jpainsymman.2016.11.006","article-title":"Cognitive interview-based validation of the patient-reported outcomes version of the common terminology criteria for adverse events in adolescents with cancer","volume":"53","author":"Reeve","year":"2017","journal-title":"Journal of pain and symptom management."},{"key":"10.1016\/j.lungcan.2022.08.021_b0130","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.lungcan.2017.09.011","article-title":"Patient-reported outcome measures (PROMs) in the management of lung cancer: a systematic review","volume":"113","author":"Bouazza","year":"2017","journal-title":"Lung Cancer."},{"issue":"3","key":"10.1016\/j.lungcan.2022.08.021_b0135","doi-asserted-by":"crossref","DOI":"10.2196\/26574","article-title":"Selecting a Subset Based on the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events for Patient-Reported Symptom Monitoring in Lung Cancer Treatment: Mixed Methods Study","volume":"7","author":"Veldhuijzen","year":"2021","journal-title":"JMIR cancer."},{"issue":"1","key":"10.1016\/j.lungcan.2022.08.021_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12955-018-0920-0","article-title":"Understanding the quality of life (QOL) issues in survivors of cancer: towards the development of an EORTC QOL cancer survivorship questionnaire","volume":"16","author":"Van Leeuwen","year":"2018","journal-title":"Health and quality of life outcomes."},{"issue":"5","key":"10.1016\/j.lungcan.2022.08.021_b0145","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jamaoncol.2016.4851","article-title":"A standard set of value-based patient-centered outcomes for breast cancer: the International Consortium for Health Outcomes Measurement (ICHOM) initiative","volume":"3","author":"Ong","year":"2017","journal-title":"JAMA oncology."},{"issue":"3","key":"10.1016\/j.lungcan.2022.08.021_b0150","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000366","article-title":"Development of a Patient Centered Outcome Set for Patients With Multiple Myeloma to be Used in Clinical Practice","volume":"4","author":"Oerlemans","year":"2020","journal-title":"HemaSphere."},{"issue":"8","key":"10.1016\/j.lungcan.2022.08.021_b0155","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/jnci\/djz094","article-title":"Sex-based heterogeneity in response to lung cancer immunotherapy: a systematic review and meta-analysis","volume":"111","author":"Conforti","year":"2019","journal-title":"JNCI: Journal of the National Cancer Institute."},{"issue":"6","key":"10.1016\/j.lungcan.2022.08.021_b0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219206","article-title":"Sex and survival in non-small cell lung cancer: a nationwide cohort study","volume":"14","author":"Radkiewicz","year":"2019","journal-title":"PloS one."},{"issue":"9","key":"10.1016\/j.lungcan.2022.08.021_b0165","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3390\/biology10090864","article-title":"Next Generation Sequencing Technology in Lung Cancer Diagnosis","volume":"10","author":"Cainap","year":"2021","journal-title":"Biology."},{"issue":"1","key":"10.1016\/j.lungcan.2022.08.021_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1745-6215-13-132","article-title":"Developing core outcome sets for clinical trials: issues to consider","volume":"13","author":"Williamson","year":"2012","journal-title":"Trials."},{"issue":"8","key":"10.1016\/j.lungcan.2022.08.021_b0175","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.ejca.2010.02.011","article-title":"Development of computerised adaptive testing (CAT) for the EORTC QLQ-C30 dimensions\u2013general approach and initial results for physical functioning","volume":"46","author":"Petersen","year":"2010","journal-title":"European Journal of Cancer."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500222006110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500222006110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:41:31Z","timestamp":1778629291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500222006110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":35,"alternative-id":["S0169500222006110"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2022.08.021","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of an updated, standardized, patient-centered outcome set for lung cancer","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2022.08.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}